» Articles » PMID: 28860561

Short Chain Fatty Acids Enhance Aryl Hydrocarbon (Ah) Responsiveness in Mouse Colonocytes and Caco-2 Human Colon Cancer Cells

Overview
Journal Sci Rep
Specialty Science
Date 2017 Sep 2
PMID 28860561
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Aryl hydrocarbon receptor (AhR) ligands are important for gastrointestinal health and play a role in gut inflammation and the induction of T regulatory cells, and the short chain fatty acids (SCFAs) butyrate, propionate and acetate also induce similar protective responses. Initial studies with butyrate demonstrated that this compound significantly increased expression of Ah-responsive genes such as Cyp1a1/CYP1A1 in YAMC mouse colonocytes and Caco-2 human colon cancer cell lines. Butyrate synergistically enhanced AhR ligand-induced Cyp1a1/CYP1A1 in these cells with comparable enhancement being observed for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and also microbiota-derived AhR ligands tryptamine, indole and 1,4-dihydroxy-2-naphthoic acid (DHNA). The effects of butyrate on enhancing induction of Cyp1b1/CYP1B1, AhR repressor (Ahrr/AhRR) and TCDD-inducible poly(ADP-ribose)polymerase (Tiparp/TiPARP) by AhR ligands were gene- and cell context-dependent with the Caco-2 cells being the most responsive cell line. Like butyrate and propionate, the prototypical hydroxyamic acid-derived histone deacetylase (HDAC) inhibitors Panobinostat and Vorinostat also enhanced AhR ligand-mediated induction and this was accompanied by enhanced histone acetylation. Acetate also enhanced basal and ligand-inducible Ah responsiveness and histone acetylation, demonstrating that acetate was an HDAC inhibitor. These results demonstrate SCFA-AhR ligand interactions in YAMC and Caco-2 cells where SCFAs synergistically enhance basal and ligand-induced expression of AhR-responsive genes.

Citing Articles

AhR governs lipid metabolism: the role of gut microbiota.

Zheng W, Liu M, Lv X, He C, Yin J, Ma J Front Microbiol. 2025; 16:1442282.

PMID: 39944639 PMC: 11817270. DOI: 10.3389/fmicb.2025.1442282.


The role of the early-life gut microbiome in childhood asthma.

Boulund U, Thorsen J, Trivedi U, Tranaes K, Jiang J, Shah S Gut Microbes. 2025; 17(1):2457489.

PMID: 39882630 PMC: 11784655. DOI: 10.1080/19490976.2025.2457489.


Increased matrix metalloproteinase-1 expression by coexposure to UVA and cigarette sidestream smoke and contribution of histone acetylation.

Ito R, Komaki Y, Ibuki Y Genes Environ. 2025; 47(1):2.

PMID: 39865280 PMC: 11765920. DOI: 10.1186/s41021-025-00325-z.


Gut dysbiosis mediates the association between antibiotic exposure and chronic disease.

Guarner F, Bustos Fernandez L, Cruchet S, Damiao A, Maruy Saito A, Riveros Lopez J Front Med (Lausanne). 2024; 11:1477882.

PMID: 39568738 PMC: 11576192. DOI: 10.3389/fmed.2024.1477882.


Contribution of tryptophan and its metabolites to transplant outcome: a mini-review.

Donoso-Meneses D, Padilla C, Moya-Guzman M, Alegre M, Pino-Lagos K Front Immunol. 2024; 15:1395421.

PMID: 39474416 PMC: 11518742. DOI: 10.3389/fimmu.2024.1395421.


References
1.
Dey A, Jones J, Nebert D . Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A2 mRNA in the mouse localized in situ hybridization. Biochem Pharmacol. 1999; 58(3):525-37. DOI: 10.1016/s0006-2952(99)00110-0. View

2.
Monteleone I, Rizzo A, Sarra M, Sica G, Sileri P, Biancone L . Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology. 2011; 141(1):237-48, 248.e1. DOI: 10.1053/j.gastro.2011.04.007. View

3.
Lukens J, Gurung P, Vogel P, Johnson G, Carter R, McGoldrick D . Dietary modulation of the microbiome affects autoinflammatory disease. Nature. 2014; 516(7530):246-9. PMC: 4268032. DOI: 10.1038/nature13788. View

4.
Fung K, Cosgrove L, Lockett T, Head R, Topping D . A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate. Br J Nutr. 2012; 108(5):820-31. DOI: 10.1017/S0007114512001948. View

5.
Busbee P, Rouse M, Nagarkatti M, Nagarkatti P . Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders. Nutr Rev. 2013; 71(6):353-69. PMC: 4076843. DOI: 10.1111/nure.12024. View